Among the most successful fund investment fields, there are Biotechnology, Agriculture. Among the most popular portfolio startups of the fund, we may highlight Bionetix.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Partners Investment, Mirae Asset Venture Investment, K Partners.
The important activity for fund was in 2017. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
| Fund Name | Location |
| Asseco South Eastern Europe | Poland, Rzeszów, Subcarpathian Voivodeship |
| Branch Bank Capital | - |
| COVID-19 Innovation Acceleration Fund. | - |
| Fogarty Institute of Innovation | California, Mountain View, United States |
| Forward Partners | England, London, United Kingdom |
| Hudson River Capital Partners | Irvington, New York, United States |
| Keli Venture Capital | - |
| Oxford Laboratories | India, Maharashtra, Mumbai |
| Tower IV | - |
| Visionnaire Ventures | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bionetix Therapeutics | $3M | 22 Dec 2017 | South Korea, Gyeonggi-do, South Korea | ||
Pinot Bio | $2M | 07 Dec 2017 | Seongnam-si, Gyeonggi-do, South Korea | ||
G+FLAS Life Sciences | $1M | 28 Feb 2017 | South Korea, Gangwon-do, South Korea | ||
Dr.Kitchen | $1M | 28 Sep 2016 | South Korea, Gyeonggi-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Bionetix Therapeutics | $3M | 22 Dec 2017 | South Korea, Gyeonggi-do, South Korea | ||
Pinot Bio | $2M | 07 Dec 2017 | Seongnam-si, Gyeonggi-do, South Korea | ||
G+FLAS Life Sciences | $1M | 28 Feb 2017 | South Korea, Gangwon-do, South Korea | ||
Dr.Kitchen | $1M | 28 Sep 2016 | South Korea, Gyeonggi-do, South Korea |
